Home > Inhibitors & Agonists > Metabolic Enzyme/Protease
Cat. No. Product name CAS No.
DC9152 Benazepril Hydrochloride

Benazepril hydrochloride, an angiotensin converting enzyme inhibitor, which is a medication used to treat high blood pressure.

86541-74-4
DC8895 benzbromaron Featured

Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout.

3562-84-3
DC11105 Umibecestat Featured

beta-secretase inhibitor.

1387560-01-1
DC7373 Betrixaban Featured

Betrixaban (PRT-054021) is a highly potent, selective, and orally efficacious factor Xa inhibitor with IC50 of 1.2 nM(inhibition of Factor 10a).

330942-05-7
DC11389 BI 409306 Featured

BI 409306 is an inhibitor of phosphodisterase 9A(PDE9A).

1189767-28-9
DC11842 BI 135585

BI 135585 (BI-135585, BI135585) is a potent, selective, orally active 11β-HSD1 inhibitor with IC50 of 4.3 nM and 53 nM in human adipocytes and primary human adipose tissue, respectively.

1114561-85-1
DC10404 BIA 10-2474 Featured

BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.

1233855-46-3
DCAPI1112 BIBR 953(Dabigatran) Featured

BIBR 953 (Dabigatran, Pradaxa) is a highly selective, reversible, and potent thrombin inhibitor and is orally available as the prodrug, dabigatran etexilate.

211914-51-1
DC1010 BIBR-1048 (Dabigatran etexilate) Featured

BIBR-1048 (Dabigatran) is an anticoagulant from the class of the direct thrombin inhibitors.

211915-06-9
DC11761 BMS-816336

A novel potent, selective, orally active human 11β-HSD1 inhibitor with IC50 of 3.0 nM.

1009583-20-3
DC10131 BMS-986205(Linrodostat) Featured

BMS-986205 is an optimized indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, is well tolerated with potent pharmacodynamic activity, alone and in combination with nivolumab in advanced cancers in a phase 1/2a trial

1923833-60-6
DC8446 BRD7116 Featured

BRD7116 competitively binds to bacterial DNA gyrase, exhibits an EC50 of 200 nM for LSCe cells, with cell-non-autonomous anti-leukemia activity.

329059-55-4
DC8089 BVT 2733(BVT.2733) Featured

BVT 2733 is a selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor,protecting osteoblasts against endogenous glucocorticoid induced dysfunction.

376640-41-4
DC8278 BVT-14225 Featured

BVT 14225 is a new selective 11b-HSD1 inhibitor, it belongs to a class of arylsulfonamidothiazoles with in vitro and in vivo antidiabetic effects

376638-65-2
DC12041 BW-A 78U Featured

BW-A 78U is a PDE4 inhibitor with an IC50 of 3 μM.

101155-02-6
DC9528 C75 (trans) Featured

C75 trans is the trans form of C75; C75 is a potent fatty-acid synthase(FASN) inhibitor with IC50 of 35.4 μM(LNCaP cell Proliferation inhibition).

191282-48-1
DC7697 CA-074-Me Featured

CA-074 Me is a selective and cell-permeable inhibitor of cathepsin B.

147859-80-1
DC8975 Captopril

Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).

62571-86-2
DC8705 Carbosulfan

Carbosulfan inhibited relatively potently CYP3A4 and moderately CYP1A1/2 and CYP2C19 in pooled HLM (human livers). Carbosulfan activation is predominantly catalyzed in humans by CYP3A4.

55285-14-8
DC9384 Carboxypeptidase G2 (CPG2) Inhibitor Featured

Carboxypeptidase G2 (CPG2) Inhibitor is a novel Carboxypeptidase G2 (CPG2) Inhibitor, Antitumor agents.

192203-60-4
DCAPI1119 Cathepsin Inhibitor 1

Cathepsin Inhibitor 1 is an inhibitor of Cathepsin (L, L2, S, K, B) with pIC50 of 7.9, 6.7, 6.0, 5.5 and 5.2, respectively.

225120-65-0
DC11709 CB-1158

CB-1158 (INCB-01158) is a potent, selective, oral available Arginase inhibitor with IC50 of 98 nM.

2095732-06-0
Page 5 / Total 81 FirstPrevNextLastGoto